Skip to content

Dating of HIV origin to 1930 is flawed, says Hooper

Toxoplasmosis, cryptococcus: safe to stop maintenance treatment after CD4 rise

No advantage to starting therapy at CD4 count above 200: cohort evidence challenges conventional wisdom

Cheaper treatment for diarrhoea, but pneumococcal vaccine useless in Africa

Post-AIDS, but not post-HIV in the North: a report from the AIDS Impact conference

Hydroxyurea debate revives: suitable drug for poor nations?

Can the immune system be rebuilt?

More than 50% ready for treatment as soon as they test HIV+

1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals